The North America Tonometer Market would witness market growth of 4.9% CAGR during the forecast period (2023-2030).
Tonometers are utilized in a test for glaucoma detection called tonometry. The pressure within the eyes can be determined by tonometry. This test can also be employed to gauge the efficacy of glaucoma treatment. Most populations deal with the serious health problem of glaucoma, which, if left untreated, can result in total blindness. The majority of cases of glaucoma are caused by a sluggish drainage of the fluid that nourishes the eye, which results in pressure buildup.
If the condition is not addressed in a timely manner, it might damage the optic nerve of the eyes and cause blindness. The increase in glaucoma incidence is the main factor fueling the growth of the market. At its most advanced stages, glaucoma, a progressive optic neuropathy, causes irreversible damage to the visual field, thinning of the retinal nerve fiber layer, and possibly loss of central visual acuity. The largest risk factor for the onset and progression of glaucoma is ocular hypertension (OHT), in which the intraocular pressure (IOP) typically exceeds 21 mmHg.
Due to the existence of major players, the elevated incidence of glaucoma, and the developed healthcare infrastructure are supporting the demand in this region. Currently, glaucoma affects more than 400,000 Canadians. In addition, the US economy loses 2.86 billion dollars annually because of glaucoma. According to the same source, 3.3 million Americans over 40 are affected by blindness or impaired eyesight. In addition, recent product introductions, an increase in optometrists, and rising consumer knowledge of various treatment choices are boosting market expansion. Therefore, the region presents lucrative growth prospects for the market in the coming years.
The US market dominated the North America Tonometer Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $135.1 million by 2030. The Canada market is estimated to witness a CAGR of 7.2% during (2023 - 2030). Additionally, The Mexico market would showcase a CAGR of 6.3% during (2023 - 2030).
Based on Type, the market is segmented into Applanation Tonometer, Rebound Tonometer, Indentation Tonometer, and Pascal Dynamic Contour Tonometer. Based on End-Use, the market is segmented into Ophthalmic Centers, Hospitals and Others. Based on Portability, the market is segmented into Desktop and Handheld. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Keeler Ltd. (Halma plc), Topcon Corporation, Revenio Group Oyj (Icare Finland Oy), Reichert, Inc. (Ametek, Inc.), OCULUS Optikgerate GmbH, Kowa American Corporation (Kowa Company, Ltd.), Nidek Co., Ltd., Ziemer Ophthalmic Systems AG, Canon, Inc. (Canon Medical Systems Corporation), and Tomey Corporation
Scope of the Study
Market Segments covered in the Report:
By Type

  • Applanation Tonometer
  • Rebound Tonometer
  • Indentation Tonometer
  • Pascal Dynamic Contour Tonometer


By End-Use

  • Ophthalmic Centers
  • Hospitals
  • Others


By Portability

  • Desktop
  • Handheld


By Country

  • US
  • Canada
  • Mexico
  • Rest of North America


Companies Profiled

  • Keeler Ltd. (Halma plc)
  • Topcon Corporation
  • Revenio Group Oyj (Icare Finland Oy)
  • Reichert, Inc. (Ametek, Inc.)
  • OCULUS Optikgerate GmbH
  • Kowa American Corporation (Kowa Company, Ltd.)
  • Nidek Co., Ltd.
  • Ziemer Ophthalmic Systems AG
  • Canon, Inc. (Canon Medical Systems Corporation)
  • Tomey Corporation


Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free